Innate Pharma S.A. Anteile 2011-2026 | IPHA

Anteile Jährlich Innate Pharma S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	79.5 M	66.9 M	66.9 M	-	-	-	-	-	-	-	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
79.5 M	66.9 M	71.1 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Keros Therapeutics KROS	37.2 M	$ 11.08	-1.47 %	$ 412 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	17.9 M	-	10.36 %	$ 9.8 M	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	54.8 M	$ 216.97	-0.5 %	$ 5 B	Danmark
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 19.25	0.1 %	$ 900 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	11.5 M	$ 0.67	10.54 %	$ 7.67 M	Israel
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	1.3 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	255 M	$ 1.4	-0.36 %	$ 357 M	Britain
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	69.9 K	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	6.28 M	$ 2.63	-	$ 16.5 M	USA
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Ligand Pharmaceuticals Incorporated LGND	18.3 M	$ 199.63	-0.36 %	$ 3.65 B	USA
Longeveron LGVN	17.6 B	$ 0.9	-5.5 %	$ 15.8 B	USA
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	192 M	$ 4.3	-2.83 %	$ 824 M	Canada
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	6.18 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	5.39 M	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
Lixte Biotechnology Holdings LIXT	1.92 M	$ 2.65	-0.38 %	$ 5.08 M	USA
Calithera Biosciences CALA	73.9 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	54.1 M	-	-3.03 %	$ 260 M	USA
Harmony Biosciences Holdings HRMY	57.5 M	$ 27.05	-1.99 %	$ 1.56 B	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA